Fundraising FoxKleinmuntz Associates
Venture capitalChicago · Seed–Series A · 2 people tracked
Find your way into Kleinmuntz Associates
Sign up to see every warm intro you have to Kleinmuntz Associates
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kleinmuntz Associates team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Founded in 2013, Kleinmuntz Associates focuses on early-stage start-up investments at the intersection of analytics, biotechnology, and healthcare. The firm combines capital investment with hands-on business advisory services, drawing on its principals' decades of operating and academic experience in healthcare analytics and decision science. Investments span molecular diagnostics, computational oncology, therapeutics, and technology-enabled consumer and SaaS platforms.
Source: firm website, verified Oct 2, 2026.
Team · 2 people
from the firm's websiteWhat they invest in
from 7 of 9 portfolio companiesBiotech ×5Medical Devices ×4AI & Machine Learning ×3Healthtech ×3Deep Tech ×2Digital Health ×1Enterprise Software ×1Future of Work ×1
HQs:United States×4
Investments · 9 tracked
founders shown can be your intro pathMarketplace enabling users to request personalized video messages or live chats with celebrities and influencers.
Steven Galanis(Founder)inMartin Blencowe(Founder)inDevon Spinnler Townsend(Founder)inArthur Leopold(Founder)Devon Townsend(Founder)
Co-investorsChaifetz GroupChicago VenturesCleo CapitalConnect VenturesDigi VenturesDuke Capital Partners+26 more
Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction.
BiotechHealthtechMedical DevicesRaleigh, US
Timothy Willis(Chief Executive Officer & Chairman of the Board)Kent Geer(Chief Financial Officer & Secretary)Tim Willis(CEO, Chairman of the Board)Ralph Stone(Chief Technology Officer)Joe Huber(Chief Operating Officer)Diethart Reichardt(Chief Marketing Officer & Board Director)
Co-investorsArieal Southeast Angel PartnersCharlotte Angel FundDuke Capital PartnersBand of AngelsCarolina Angel NetworkDeepWork Capital+2 more
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)inMatt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsAvenir Growth CapitalB3 HoldingOctave Ventures LlcOCV PartnersOMX VenturesShumway Capital+2 more
OMX is a venture capital firm investing in life sciences and biotechnology companies across therapeutics, synthetic biology, and diagnostics.
BiotechDeep Tech
Origin Ventures is an early-stage venture capital firm that leads Seed and Series A rounds in companies building AI infrastructure, software, applications, services, and marketplaces focused on productivity and automation.
AI & Machine Learning
SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.
AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US
Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)inStacey Stevens(Executive Officer, Director)in
BoardVikram Chaudhery(Director)inLucy Coassin(Director)
Co-investorsAV8 VenturesGenoa VenturesGENERAL INCEPTIONNorthpond Ventures
StatusNow provides a communications and availability tool that gives organizations a real-time, global view of staff availability based on profiles such as skills, location, and expertise.
Enterprise SoftwareFuture of WorkSaaS
VedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Diego, US
Anurup Ganguli(Founder)inFred(President and CEO)Frédéric Sweeney(President and Chief Executive Officer)inMaurice Exner(Chief Operating Officer)in
Co-investorsIllinois VenturesOMX VenturesY CombinatorEvergreen Venture PartnersFox Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CampfireSocial
Portfolio news
latest coverage across their companiesFrequently asked questions
- How many investments has Kleinmuntz Associates made?
- Kleinmuntz Associates has 9 tracked investments.
- What stage does Kleinmuntz Associates invest at?
- Kleinmuntz Associates invests at the Seed, Series A stages.
- What sectors does Kleinmuntz Associates focus on?
- Kleinmuntz Associates focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Kleinmuntz Associates located?
- Kleinmuntz Associates is headquartered in Chicago, US.
- Who does Kleinmuntz Associates co-invest with?
- Kleinmuntz Associates most often shares deals with Duke Capital Partners, OMX Ventures, Connect Ventures, among 35 tracked co-investors.
Media · Podcasts & interviews
featuring the teamInterview with Don Kleinmuntz, 2009 INFORMS President
INFORMS · Don Kleinmuntz
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.